Diabetes mellitus is associated with high early-mortality and poor prognosis in patients with autoimmune hemolytic anemia

Hematology

Volumn 14, Issue 6, 2009, Pages 361-365

  Nakasone, Hideki ^a,b   Kako, Shinichi ^a   Endo, Hiroshi ^b   Ito, Ayumu ^b   Sato, Miki ^a   Terasako, Kiriko ^a   Okuda, Shinya ^a   Tanaka, Yukie ^a   Yamazaki, Rie ^a   Oshima, Kumi ^a   Tanihara, Aki ^a   Kida, Michiko ^b   Higuchi, Takakazu ^a   Izutsu, Koji ^b   Nishida, Junji ^a   Urabe, Akio ^b   Usuki, Kensuke ^b   Kanda, Yoshinobu ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Nippon Telegraph and Telephone Corporation Medical Center Tokyo   (Japan)

Author keywords

Autoimmune hemolytic anemia; Diabetes; Prognostic markers

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ADULT; ADULT ONSET STILL DISEASE; AGED; ARTICLE; ASPERGILLOSIS; AUTOIMMUNE HEMOLYTIC ANEMIA; CANCER CHEMOTHERAPY; CAUSE OF DEATH; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HODGKIN DISEASE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MILIARY TUBERCULOSIS; MORTALITY; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PSEUDOMONAS AERUGINOSA; RISK FACTOR; SJOEGREN SYNDROME; SURVIVAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA, HEMOLYTIC, AUTOIMMUNE; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 71049120965     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453309X12473408860262     Document Type: Article

References (25)

1. Hendrick AM. Auto-immune haemolytic anaemia - a high-risk disorder for thromboembolism? Hematology 2003; 8(1): 53-56.
2. Barker RN, Hall AM, Standen GR, Jones J, Elson CJ. Identification of T-cell epitopes on the Rhesus polypeptides in autoimmune hemolytic anemia. Blood 1997; 90(7): 2701-2715.
3. Ward FJ, Hall AM, Cairns LS et al. Clonal regulatory T cells specific for a red blood cell autoantigen in human autoimmune hemolytic anemia. Blood 2008; 111(2): 680-687.
4. Allgood JW, Chaplin H, Jr. Idiopathic acquired autoimmune hemolytic anemia. A review of forty-seven cases treated from 1955 through 1965. Am J Med 1967; 43(2): 254-273.
5. Standards of medical care in diabetes - 2008. Diabetes Care 2008; 31(Suppl 1): S12-54.
6. Genuth S, Alberti KG, Bennett P et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26(11): 3160-3167.
7. Muller LM, Gorter KJ, Hak E et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 2005; 41(3): 281-288.
8. Lang CC, Beniaminovitz A, Edwards N, Mancini DM. Morbidity and mortality in diabetic patients following cardiac transplantation. J Heart Lung Transplant 2003; 22(3): 244-249.
9. Livi U, Caforio AL, Grassi G et al. Mid-term results of heart transplantation in diabetic patients. J Cardiovasc Surg (Torino) 1994; 35(6 Suppl 1): 115-118.
10. Molad Y, Levin-Iaina N, Vaturi M, Sulkes J, Sagie A. Heart valve calcification in young patients with systemic lupus erythematosus: a window to premature atherosclerotic vascular morbidity and a risk factor for all-cause mortality. Atherosclerosis 2006; 185(2): 406-412.
11. Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005; 52(3): 722-732.
12. Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 2002; 46(9): 2287-2293.
13. Blanco FJ, Gomez-Reino JJ, de la Mata J et al. Survival analysis of 306 European Spanish patients with systemic lupus erythematosus. Lupus 1998; 7(3): 159-163.
14. Jacobsen S, Petersen J, Ullman S et al. A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value. Clin Rheumatol 1998; 17(6): 478-484. (Pubitemid 28566324)
15. Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B. Impaired leucocyte functions in diabetic patients. Diabet Med 1997; 14(1): 29-34.
16. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med 1999; 341(25): 1906-1912.
17. Stegenga ME, van der Crabben SN, Blumer RM et al. Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood 2008; 112(1): 82-89.
18. Leon B, Ardavin C. Monocyte migration to inflamed skin and lymph nodes is differentially controlled by L-selectin and PSGL-1. Blood 2008; 111(6): 3126-3130.
19. McGettrick HM, Hunter K, Moss PA, Buckley CD, Rainger GE, Nash GB. Direct observations of the kinetics of migrating T cells suggest active retention by endothelial cells with continual bidirectional migration. J Leukoc Biol 2009; 85: 98-107.
20. Ou R, Zhang M, Huang L, Flavell RA, Koni PA, Moskophidis D. Regulation of immune response and inflammatory reactions against viral infection by VCAM-1. J Virol 2008; 82(6): 2952-2965.
21. Tepper OM, Galiano RD, Capla JM et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002; 106(22): 2781-2786.
22. Nilsson TK, Sondell KM, Norberg BO, Back O. Plasma levels of endothelial-derived haemostatic factors in autoimmune thrombocytopenia and haemolytic anaemia. J Intern Med 1990; 228(3): 249-252.
23. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005; 293(13): 1653-1662.
24. Giles FJ, Borthakur G, Ravandi F et al. The haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukaemia. Br J Haematol 2007; 136(4): 624-627.
25. Sorror ML, Maris MB, Storb R et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005; 106(8): 2912-2919.